ARCHIVES

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

This article is from The Cancer Letter archive.

Vol. 16 No. 08 | February 23, 1990

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

In Brief: Golomb, Weinstein Head ASCO, AACR; Abeloff, Moses Presidents Elect; Sackett Heads AUR

June 1, 1990

Pas Available; Alternative Medicine

January 21, 1994

Merritt To Head Nursing Center’s Implementation; Nurse Research And Training Opportunities Varied

January 10, 1986